Current Online CE Programs

While the CDC recommends that all patients in all health care settings be tested for HIV, screening is especially critical in pregnant women because the overwhelming majority of pediatric HIV cases result from perinatal trans- mission. This case study will illustrate how early testing in pregnancy can set the stage for the most effective interventions to prevent transmission to the newborn, and will provide an outline of initial treatment strategies for the pregnant patient with HIV.

After taking part in this educational activity, participants should be better able to:

• Discuss the importance of opt-out HIV testing for pregnant women to prevent perinatal transmission
• Provide initial counseling and referrals for pregnant patients who test positive for HIV

.5 Contact Hours  •  .5 Pharmacology Hours

Release date: November 15, 2011  •  Expires: November 30, 2012

This online CE activity will help primary care clinicians improve their performance in terms of HIV identification and co-management. Surmounting barriers to opt-out screening, making an HIV diagnosis, and prevention of opportunistic infections will be discussed, as will selection of initial antiretroviral therapy (ART) and considerations for patients receiving ART.

After taking part in this educational activity, participants should be better able to:

• Describe the rationale for implementing “opt-out” HIV testing, as recommended by the CDC
• Address issues and potential barriers to routine HIV screening
• Identify the signs and symptoms of acute HIV infection
• Address issues pertinent to the co-management of patients with HIV, including considerations for those receiving antiretroviral therapy

.5 Contact Hours  •  .5 Pharmacology Hours

Release date: September 23, 2011  •  Expires: September 23, 2012

This online CE activity will provide learners with a practical illustration of how the latest recommendations for HIV opt-out screening should be applied in the primary care setting, and how a positive test result can be delivered to a young patient and her family.

After taking part in this educational activity, participants should be better able to:

• Discuss the importance of opt-out HIV testing for all individuals, regardless of established risk factors
• Implement initial treatment decisions for a patient with newly diagnosed HIV

.5 Contact Hours   •   .5 Pharmacology Hours

Release date: August 12, 2011   •   Expires: August 31, 2012

Type 2 Diabetes: Current and Evolving
Treatment Options

Nearly 27 million American adults have type 2 diabetes mellitus (T2DM) or the metabolic syndrome; of these, 6 million individuals with T2DM remain undiagnosed. At least 57 million more American adults are at high risk for developing T2DM. As front-line clinicians in the care of patients with T2DM, primary care clinicians need to be aware of the benefits and risks of available and emerging treatments for T2DM and be able to effectively tailor therapy to the needs of the patient, taking into consideration findings regarding CV and renal risk reduction and revised guidelines to maximize patient outcomes.

Upon completion of this activity, participants should be better able to:

• Delineate the prevalence and impact of type 2 diabetes mellitus (T2DM) and associated complications
• Illustrate evidence-based guidelines for early and intensive therapeutic strategies to ensure optimal glycemic control and to mitigate the risk of micro- and macrovascular complications of T2DM
• Compare and contrast the efficacy, safety, and tolerability of currently available and emerging classes of medications for the management of T2DM
• Describe the prevalence and impact of chronic kidney disease (CKD) associated with T2DM and outline the importance of early diagnostic screening of renal disease to ensure appropriate therapeutic intervention
• Identify 2 collaborative in-office clinical and practice-management protocols that assist NPs, PAs, and other providers in improving care for patients with T2DM and strengthening adherence to the treatment plan

1.0 Contact Hours   •   .5 Pharmacology Hours

Release date: December 1, 2010   •   Expires: June 30, 2012